HFA News

HFA news, HF Congress news, ESC Press on HF

• 28/08/2023 DICTATE-AHF trial fails to meet primary endpoint with dapagliflozin in acute heart failure (Read more)
• 28/08/2023 Natriuresis guided diuretic therapy increases natriuresis in acute heart failure patients (Read more)
• 27/08/2023 Atrial fibrillation ablation improves outcomes in patients with end-stage heart failure (Read more)
• 26/08/2023 First randomised trial of traditional Chinese medicine for heart failure shows benefit (Read more)
• 26/08/2023 Upgrade to cardiac resynchronisation therapy benefits heart failure patients with pacing (Read more)
• 26/08/2023 Iron therapy linked with reduced hospitalisation in iron-deficient heart failure patients (Read more)
• 26/08/2023 Trial of ferric carboxymaltose in heart failure does not meet primary endpoint (Read more)
• 25/08/2023 Weight loss medication benefits patients with heart failure and obesity (Read more)
• 25/08/2023 Focused update of ESC Heart Failure Guidelines published today (Read more)
• 21/06/2023 Artificial intelligence set to personalise treatment of heart failure patients (Read more)
• 22/05/2023 Women more likely to die after heart attack than men (Read more)
• 22/05/2023 Dirty air linked with premature death in patients with heart failure (Read more)
• 22/05/2023 The diagnosis of heart failure is more often missed than made especially for women (Read more)
• 21/05/2023 Sacubitril/valsartan shows benefit in heart failure with ejection fraction above 40% (Read more)
• 20/05/2023 Remote monitoring reduces heart failure hospitalisations and improves quality of life (Read more)
• 20/05/2023 Heart attack patients with strong legs have better prognosis (Read more)
• 28/04/2023 Heart Failure 2023: discover the future of heart failure therapy (Read more)
• 18/04/2023 Novel score predicts heart failure improvement after atrial fibrillation ablation (Read more)
• 15/04/2023 Detailed guidance on natural pacemaker method published today (Read more)
• 22/03/2023 Study shows ‘obesity paradox’ does not exist: waist-to-height ratio is a better indicator of outcomes in patients with heart failure than BMI (Read more)
• 07/11/2022 Mirabegron is safe but fails to prevent remodelling in patients with mild heart failure (Read more)
• 17/10/2022 ESC Asia 2022 with APSC & AFC: state-of-the-art cardiovascular science in the Asia Pacific (Read more)